NLM Logo

Clinical Trial, Phase IV MeSH Descriptor Data 2024

MeSH Heading
Clinical Trial, Phase IV
Tree Number(s)
Unique ID
RDF Unique Identifier
this heading is used as a Publication Type; for original report of the conduct or results of a specific phase IV clinical trial; a different heading CLINICAL TRIALS, PHASE IV AS TOPIC is used for general design, methodology, economics, etc. of phase IV clinical trials.
Scope Note
Work that is a report of a planned post-marketing study of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale after clinical trials, phases I, II, and III. These studies, conducted in the United States or a foreign country, often garner additional data about the safety and efficacy of a product.
Entry Term(s)
Clinical Trial, Phase 4
History Note
Date Established
Date of Entry
Revision Date

No Qualifiers
Clinical Trial, Phase IV Preferred
page delivered in 0.142s